Qiang Tu
Overview
Explore the profile of Qiang Tu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
2254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zheng W, Wang Y, Cui J, Guo G, Li Y, Hou J, et al.
Nat Commun
. 2024 Nov;
15(1):9790.
PMID: 39532871
The complexities encountered in microbial metabolic engineering continue to elude prediction and design. Unravelling these complexities requires strategies that go beyond conventional genetics. Using multiplex mutagenesis with double stranded (ds)...
12.
Fu Y, Luo X, Li J, Mo Q, Wang X, Zhao Y, et al.
Elife
. 2024 Nov;
13.
PMID: 39508089
The gut microbiota is implicated in the pathogenesis of hyperuricemia (HUA) and gout. However, it remains unclear whether probiotics residing in the host gut, such as , can prevent HUA...
13.
Tu Q, Hyun K, Lin S, Hafiz N, Manandi D, Zhang Q, et al.
J Diabetes Complications
. 2024 Oct;
38(11):108878.
PMID: 39418939
Aims: To assess the individual and joint effects of diabetes and depression on all-cause mortality and cardiovascular disease (CVD) in the middle-aged and elderly Chinese populations. Methods: 9105 individuals without...
14.
Feng T, Wang X, Shi Y, Tu Q
J Environ Manage
. 2024 Oct;
370:122787.
PMID: 39362165
The carbon emission trading scheme (ETS), a market-based environmental regulation, is critical for in combating climate change in China. According to the Porter effect, ETS can promote green innovation, while...
15.
Fang H, Ke Q, Wu S, Tu Q, Wang L
Front Immunol
. 2024 Aug;
15:1421520.
PMID: 39156893
Background: Transarterial chemo(embolization) is preferred for treating unresectable hepatocellular carcinoma (uHCC); however, because of emerging immune-targeted therapies, its efficacy is at stake. This systematic review pioneers to evaluate the clinical...
16.
Zhu G, Wang X, Du R, Wen S, Du L, Tu Q
Microorganisms
. 2024 Jul;
12(7).
PMID: 39065174
Immobilized microbial technology has recently emerged as a prominent research focus for the remediation of heavy metal pollution because of its superior treatment efficiency, ease of operation, environmental friendliness, and...
17.
Tu Q, Lin S, Hyun K, Hafiz N, Manandi D, Koh A, et al.
Prim Care Diabetes
. 2024 Jun;
18(4):381-392.
PMID: 38852029
Background: Multidisciplinary collaborative care has been widely recommended as an effective strategy for managing diabetes; however, the cardiovascular risk factors of patients with diabetes are often inadequately managed in primary...
18.
Hafiz N, Hyun K, Tu Q, Knight A, Hespe C, Chow C, et al.
PLoS One
. 2024 Jun;
19(6):e0298777.
PMID: 38833486
Background: This study evaluates primary care practices' engagement with various features of a quality improvement (QI) intervention for patients with coronary heart disease (CHD) in four Australian states. Methods: Twenty-seven...
19.
He H, Zheng W, Xiao S, Gong L, Li H, Zhou K, et al.
J Agric Food Chem
. 2024 May;
72(22):12618-12629.
PMID: 38778776
Microbial nitrogen fixation presents a viable alternative to chemical fertilizers, yet the limited colonization and specificity of naturally occurring nitrogen-fixing microorganisms present significant challenges to their widespread application. In this...
20.
Jin Z, Chen J, Zhu X, Duan X, Xin Y, Zhong B, et al.
EClinicalMedicine
. 2024 May;
72:102622.
PMID: 38745965
Background: The role of transarterial chemoembolization (TACE) in the treatment of advanced hepatocellular carcinoma (HCC) is unconfirmed. This study aimed to assess the efficacy and safety of immune checkpoint inhibitors...